Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study

Clostridioides difficile infection (CDI) remains a major healthcare problem worldwide, however, little is known about CDI epidemiology in Iran. Between December 2004 and November 2018, 3649 stool samples were collected from patients in 69 hospitals and medical centres in Tehran and were cultured for...

Full description

Saved in:
Bibliographic Details
Main Authors: Masoumeh Azimirad, Marcela Krutova, Abbas Yadegar, Shabnam Shahrokh, Meysam Olfatifar, Hamid Asadzadeh Aghdaei, Warren N. Fawley, Mark H. Wilcox, Mohammad Reza Zali
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1780949
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187073499168768
author Masoumeh Azimirad
Marcela Krutova
Abbas Yadegar
Shabnam Shahrokh
Meysam Olfatifar
Hamid Asadzadeh Aghdaei
Warren N. Fawley
Mark H. Wilcox
Mohammad Reza Zali
author_facet Masoumeh Azimirad
Marcela Krutova
Abbas Yadegar
Shabnam Shahrokh
Meysam Olfatifar
Hamid Asadzadeh Aghdaei
Warren N. Fawley
Mark H. Wilcox
Mohammad Reza Zali
author_sort Masoumeh Azimirad
collection DOAJ
description Clostridioides difficile infection (CDI) remains a major healthcare problem worldwide, however, little is known about CDI epidemiology in Iran. Between December 2004 and November 2018, 3649 stool samples were collected from patients in 69 hospitals and medical centres in Tehran and were cultured for the presence of C. difficile; isolates were characterized by PCR ribotyping and toxin genes detection. A total of 582 C. difficile isolates were obtained and the overall CDI prevalence was 15.9%; 290 (49.8%) cases were healthcare-associated (HA) and 292 (50.2%) cases were community-associated (CA). Of these, DNA of 513 isolates submitted for ribotyping. The ribotype and/or WEBRIBO type could be assessed in 366 (62.9%) isolates. The most frequent RTs were 001 (n = 75, 12.9%), 126 (n = 65, 11.2%) and 084 (n = 19, 3.3%); the toxin gene profile tcdA+B+/cdtA+B+ (n = 112, 19.2%) was the most common. Fifteen C. difficile isolates (2.6%) did not carry any toxin genes. There was no difference between frequently found RTs in HA-CDI and CA-CDI, except for RT 029 which was more likely to be associated with healthcare origin (12/15, p-value = 0.02). No isolate of RTs 027 or 078 was identified. Importantly, RTs 031, 038, 039, 084, 085 reported previously as RTs with an absence of toxin genes, revealed the presence of toxin genes in our study. Using Simpson’s reciprocal index of diversity, we found that RT diversity decreased as the prevalence of the RT 084 increased (R = −0.78, p-value = 0.041). Different patterns in CDI epidemiology underscore the importance of local surveillance and infection control measures in Tehran healthcare settings.
format Article
id doaj-art-3528fa5db9f442cebba5f17bfb3c750e
institution OA Journals
issn 2222-1751
language English
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj-art-3528fa5db9f442cebba5f17bfb3c750e2025-08-20T02:16:11ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-01911432144310.1080/22221751.2020.1780949Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional studyMasoumeh Azimirad0Marcela Krutova1Abbas Yadegar2Shabnam Shahrokh3Meysam Olfatifar4Hamid Asadzadeh Aghdaei5Warren N. Fawley6Mark H. Wilcox7Mohammad Reza Zali8Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Medical Microbiology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech RepublicFoodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, IranGastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, IranGastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, IranBasic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, IranEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides Difficile (ESGCD)European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides Difficile (ESGCD)Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, IranClostridioides difficile infection (CDI) remains a major healthcare problem worldwide, however, little is known about CDI epidemiology in Iran. Between December 2004 and November 2018, 3649 stool samples were collected from patients in 69 hospitals and medical centres in Tehran and were cultured for the presence of C. difficile; isolates were characterized by PCR ribotyping and toxin genes detection. A total of 582 C. difficile isolates were obtained and the overall CDI prevalence was 15.9%; 290 (49.8%) cases were healthcare-associated (HA) and 292 (50.2%) cases were community-associated (CA). Of these, DNA of 513 isolates submitted for ribotyping. The ribotype and/or WEBRIBO type could be assessed in 366 (62.9%) isolates. The most frequent RTs were 001 (n = 75, 12.9%), 126 (n = 65, 11.2%) and 084 (n = 19, 3.3%); the toxin gene profile tcdA+B+/cdtA+B+ (n = 112, 19.2%) was the most common. Fifteen C. difficile isolates (2.6%) did not carry any toxin genes. There was no difference between frequently found RTs in HA-CDI and CA-CDI, except for RT 029 which was more likely to be associated with healthcare origin (12/15, p-value = 0.02). No isolate of RTs 027 or 078 was identified. Importantly, RTs 031, 038, 039, 084, 085 reported previously as RTs with an absence of toxin genes, revealed the presence of toxin genes in our study. Using Simpson’s reciprocal index of diversity, we found that RT diversity decreased as the prevalence of the RT 084 increased (R = −0.78, p-value = 0.041). Different patterns in CDI epidemiology underscore the importance of local surveillance and infection control measures in Tehran healthcare settings.https://www.tandfonline.com/doi/10.1080/22221751.2020.1780949Clostridioides difficileribotypingIranCDIepidemiologyclinical features
spellingShingle Masoumeh Azimirad
Marcela Krutova
Abbas Yadegar
Shabnam Shahrokh
Meysam Olfatifar
Hamid Asadzadeh Aghdaei
Warren N. Fawley
Mark H. Wilcox
Mohammad Reza Zali
Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
Emerging Microbes and Infections
Clostridioides difficile
ribotyping
Iran
CDI
epidemiology
clinical features
title Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
title_full Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
title_fullStr Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
title_full_unstemmed Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
title_short Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
title_sort clostridioides difficile ribotypes 001 and 126 were predominant in tehran healthcare settings from 2004 to 2018 a 14 year long cross sectional study
topic Clostridioides difficile
ribotyping
Iran
CDI
epidemiology
clinical features
url https://www.tandfonline.com/doi/10.1080/22221751.2020.1780949
work_keys_str_mv AT masoumehazimirad clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy
AT marcelakrutova clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy
AT abbasyadegar clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy
AT shabnamshahrokh clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy
AT meysamolfatifar clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy
AT hamidasadzadehaghdaei clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy
AT warrennfawley clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy
AT markhwilcox clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy
AT mohammadrezazali clostridioidesdifficileribotypes001and126werepredominantintehranhealthcaresettingsfrom2004to2018a14yearlongcrosssectionalstudy